NCT00000209View on ClinicalTrials.gov

Buprenorphine Dosing Interval - 5

PHASE2CompletedINTERVENTIONAL

0

Timeline

Start Date

November 30, 1992

Conditions

Opioid-Related Disorders

Interventions

DRUG

Buprenorphine

Trial Locations (1)

90025

Friends Research Institute, Los Angeles

All Listed Sponsors

lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00000209 - Buprenorphine Dosing Interval - 5 | Biotech Hunter | Biotech Hunter